Technology
Health
Biotechnology

Veracyte

528

$24.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.87 (+3.65%) Today
$0.00 (0.00%) As of 4:01 PM EST after-hours

Why Robinhood?

You can buy or sell Veracyte and other stocks, options, ETFs, and crypto commission-free!

About VCYT

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. Read More It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

CEO
Bonnie H. Anderson
Employees
354
Headquarters
South San Francisco, California
Founded
2006
Market Cap
1.15B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
533.26K
High Today
$24.73
Low Today
$22.95
Open Price
$22.95
Volume
644.20K
52 Week High
$31.18
52 Week Low
$18.55

Collections

Technology
Health
Biotechnology
Cancer Prevention
2013 IPO
US
North America
Female CEOs

VCYT Earnings

-$0.27
-$0.19
-$0.10
-$0.02
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
-$0.07 per share
Actual
-$0.15 per share
Replay Earnings Call

People Also Bought

Invitae

12,380

$20.38

+0.74%

Invitae

12,380

$20.38

+0.74%

CRISPR

26,845

$53.60

+8.41%

Zscaler

6,669

$52.02

+4.58%

NeoGenomics

2,676

$28.33

+2.98%

Stitch Fix

19,217

$24.03

+1.01%

Appian

11,033

$44.15

-1.93%

Smartsheet

3,844

$46.30

+1.65%

Etsy

14,426

$58.99

+1.85%

Sonos

10,559

$11.54

-0.52%

Fastly

6,772

$19.90

+1.48%

Revolve Group

9,145

$16.30

+4.62%

Health Catalyst

1,221

$30.38

+9.52%

You May Also Like

SDAG
SIVR
PNR
UNICY
EFAV
SFY
QUAL
UMDD
DDS
NEWA
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy VCYT

Market Price$24.69
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Veracyte stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up